{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:17:54Z","timestamp":1790054274420,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1378\/chest.13-1607","type":"journal-article","created":{"date-parts":[[2014,1,23]],"date-time":"2014-01-23T16:11:29Z","timestamp":1390493489000},"page":"1114-1120","source":"Crossref","is-referenced-by-count":16,"title":["Impact of Macrolide Therapy in Patients Hospitalized With Pseudomonas aeruginosa Community-Acquired Pneumonia"],"prefix":"10.1016","volume":"145","author":[{"given":"Elena","family":"Laserna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oriol","family":"Sibila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Felipe","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Jose","family":"Maselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Mortensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Anzueto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Waterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos I.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1378\/chest.13-1607_bib1","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1086\/511159","article-title":"Infectious Diseases Society of America\/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults","volume":"44","author":"Mandell","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1378\/chest.13-1607_bib2","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1183\/09031936.05.00055705","article-title":"Guidelines for the management of adult lower respiratory tract infections [published correction appears in Eur Respir J. 2006;27(2):439]","volume":"26","author":"Woodhead","year":"2005","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.13-1607_bib3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/CMR.00078-09","article-title":"Mechanisms of action and clinical application of macrolides as immunomodulatory medications","volume":"23","author":"Kanoh","year":"2010","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1378\/chest.13-1607_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ijantimicag.2007.08.001","article-title":"Macrolides beyond the conventional antimicrobials: a class of potent immunomodulators","volume":"31","author":"Giamarellos-Bourboulis","year":"2008","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"10.1378\/chest.13-1607_bib5","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/jac\/dkh519","article-title":"Anti-inflammatory effects of macrolides\u2014an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?","volume":"55","author":"Amsden","year":"2005","journal-title":"J Antimicrob Chemother"},{"issue":"15","key":"10.1378\/chest.13-1607_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1378\/chest.13-1607_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Mart\u00ednez","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1378\/chest.13-1607_bib8","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1164\/rccm.200311-1578OC","article-title":"Combination antibiotic therapy lowers mortality among severely ill patients with pneumococcal bacteremia","volume":"170","author":"Baddour","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1378\/chest.13-1607_bib9","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1378\/chest.06-1426","article-title":"Antibiotics for bacteremic pneumonia: improved outcomes with macrolides but not fluoroquinolones","volume":"131","author":"Metersky","year":"2007","journal-title":"Chest"},{"issue":"6","key":"10.1378\/chest.13-1607_bib10","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/01.CCM.0000266755.75844.05","article-title":"Combination antibiotic therapy improves survival in patients with community-acquired pneumonia and shock","volume":"35","author":"Rodr\u00edguez","year":"2007","journal-title":"Crit Care Med"},{"issue":"1","key":"10.1378\/chest.13-1607_bib11","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1183\/09031936.00054108","article-title":"Impact of macrolide therapy on mortality for patients with severe sepsis due to pneumonia","volume":"33","author":"Restrepo","year":"2009","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1378\/chest.13-1607_bib12","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.10-0166","article-title":"Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source","volume":"139","author":"Fujitani","year":"2011","journal-title":"Chest"},{"issue":"16","key":"10.1378\/chest.13-1607_bib13","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk, and prognosis","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1378\/chest.13-1607_bib14","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1183\/09031936.00091809","article-title":"Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors","volume":"35","author":"von Baum","year":"2010","journal-title":"Eur Respir J"},{"issue":"12","key":"10.1378\/chest.13-1607_bib15","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"issue":"13","key":"10.1378\/chest.13-1607_bib16","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.290.13.1749","article-title":"Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial","volume":"290","author":"Saiman","year":"2003","journal-title":"JAMA"},{"issue":"8","key":"10.1378\/chest.13-1607_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1378\/chest.13-1607_bib18","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1164\/ajrccm.157.6.9710075","article-title":"Improvement of survival in patients with diffuse panbronchiolitis treated with low-dose erythromycin","volume":"157","author":"Kudoh","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"10.1378\/chest.13-1607_bib19","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"9","key":"10.1378\/chest.13-1607_bib20","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archinte.162.9.1059","article-title":"Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study","volume":"162","author":"Mortensen","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1378\/chest.13-1607_bib21","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-4-2","article-title":"Accuracy and completeness of mortality data in the Department of Veterans Affairs","volume":"4","author":"Sohn","year":"2006","journal-title":"Popul Health Metr"},{"issue":"5","key":"10.1378\/chest.13-1607_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1183\/09031936.06.00126004","article-title":"Impact of initial antibiotic choice on mortality from pneumococcal pneumonia","volume":"27","author":"Aspa","year":"2006","journal-title":"Eur Respir J"},{"issue":"8","key":"10.1378\/chest.13-1607_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s10096-006-0183-2","article-title":"Addition of a macrolide to a \u03b2-lactam in bacteremic pneumococcal pneumonia","volume":"25","author":"Dwyer","year":"2006","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"3","key":"10.1378\/chest.13-1607_bib24","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1183\/09031936.00031007","article-title":"The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis","volume":"30","author":"Paul","year":"2007","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1378\/chest.13-1607_bib25","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/cid\/cis414","article-title":"Macrolide-based regimens and mortality in hospitalized patients with community-acquired pneumonia: a systematic review and meta-analysis","volume":"55","author":"Asadi","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1378\/chest.13-1607_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1164\/rccm.201002-0272CI","article-title":"Management of community-acquired pneumonia in adults","volume":"183","author":"Waterer","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1378\/chest.13-1607_bib27","doi-asserted-by":"crossref","first-page":"e1000354","DOI":"10.1371\/journal.ppat.1000354","article-title":"Assembly and development of the Pseudomonas aeruginosa biofilm matrix","volume":"5","author":"Ma","year":"2009","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1378\/chest.13-1607_bib28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1128\/AAC.48.1.93-99.2004","article-title":"Immunomodulatory clarithromycin treatment of experimental sepsis and acute pyelonephritis caused by multidrug-resistant Pseudomonas aeruginosa","volume":"48","author":"Giamarellos-Bourboulis","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"8","key":"10.1378\/chest.13-1607_bib29","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10096-008-0485-7","article-title":"Clinical outcomes and risk factors of community-acquired pneumonia caused by gram-negative bacilli","volume":"27","author":"Kang","year":"2008","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"1","key":"10.1378\/chest.13-1607_bib30","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1440-1843.2008.01371.x","article-title":"Risk factors and outcome of community-acquired pneumonia due to gram-negative bacilli","volume":"14","author":"Falguera","year":"2009","journal-title":"Respirology"},{"issue":"6","key":"10.1378\/chest.13-1607_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1177\/1062860605280358","article-title":"Accuracy of administrative data for identifying patients with pneumonia","volume":"20","author":"Aronsky","year":"2005","journal-title":"Am J Med Qual"},{"issue":"4","key":"10.1378\/chest.13-1607_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S1473-3099(10)70032-3","article-title":"Rethinking the concepts of community-acquired and health-care-associated pneumonia","volume":"10","author":"Ewig","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"10.1378\/chest.13-1607_bib33","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1183\/09031936.00141110","article-title":"Guideline-concordant therapy and outcomes in healthcare-associated pneumonia","volume":"38","author":"Attridge","year":"2011","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215346043?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369215346043?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:40:08Z","timestamp":1655944808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369215346043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0012369215346043"],"URL":"https:\/\/doi.org\/10.1378\/chest.13-1607","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}